Retinal Capillary Perfusion Tied to Cerebral Small Vessel Disease in Black Patients
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 1, 2023 -- Lower retinal capillary perfusion is associated with cerebral small vessel disease, according to a study published online Oct. 6 in Alzheimer’s & Dementia.
Farzan Abdolahi, M.D., from University of Southern California in Los Angeles, and colleagues investigated whether retinal capillary perfusion, measured using optical coherence tomography angiography (OCTA), is a biomarker of cerebral small vessel disease and impaired cognition among Black Americans. Analysis included 96 Black Americans without known cognitive impairment.
The researchers found that lower retinal capillary perfusion was correlated with worse Oral Symbol Digit Test and Fluid Cognition Composite scores, but not with the Crystallized Cognition Composite score. There was also a correlation seen between lower retinal perfusion and higher free water and peak width of skeletonized mean diffusivity, and lower fractional anisotropy on magnetic resonance imaging.
“As a noninvasive, rapid, easy-to-administer, and U.S. Food and Drug Administration-approved imaging modality, OCTA may be particularly useful for screening underdiagnosed, underserved, high-risk populations such as Black Americans," the authors write.
Two authors disclosed ties to Carl Zeiss Meditec, which developed the OCTA used in the study.
Source: HealthDay
Posted : 2023-11-01 22:52
Read more
- 'Dawson's Creek' Star James Van Der Beek Has Colon Cancer
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Why Alarm Is Easing Over a Rise in Pancreatic Cancer Among the Young
- Poll Finds Most Americans Stressed Over Election, Future of Nation
- Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions